// App-Quantinova.ai

PB1738 : REAL-WORLD COSTS OF FRONT-LINE TREATMENT FOR PERIPHERAL T-CELL LYMPHOMA IN FRANCE, GERMANY, AND THE UNITED KINGDOM

Researchers

Presenter

  • Christopher Fox

Principal Investigators

  • Ajibade Ashaye

  • Ruchit Shah

  • Shelby Corman

  • Mehul Dalal

  • Lorenz Trumper

Medical Centers

  • Pharmerit-an Open Health Company,Bethesda,United States

  • University Medical Center, Georg-August University, Goettingen, Germany

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • Global Outcomes Research,Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited,Cambridge,United States

Locations

  • United States

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved